• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Comprehensive Overview of tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate (CAS No. 719999-55-0)

tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate (CAS No. 719999-55-0) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This compound belongs to the class of carbamate derivatives, which are known for their versatility in medicinal chemistry. The presence of the pyrrolidine ring and the tert-butyl group makes it a valuable intermediate for designing bioactive molecules, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors.

In recent years, the demand for chiral building blocks like tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate has surged due to their critical role in asymmetric synthesis. Researchers are increasingly focusing on stereoselective reactions to create enantiomerically pure compounds, which are essential for drug efficacy and safety. This compound's (2S)-pyrrolidin-2-yl moiety is particularly noteworthy, as it mimics natural alkaloids and can enhance binding affinity to biological targets.

The synthesis of tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate typically involves multi-step organic reactions, including Boc protection (tert-butoxycarbonyl) of the amine group. This protection strategy is a cornerstone in peptide chemistry and drug design, ensuring selective reactivity during complex syntheses. The compound's CAS No. 719999-55-0 is frequently referenced in patent literature, highlighting its importance in proprietary drug development pipelines.

From an industrial perspective, tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate is often discussed in the context of green chemistry and sustainable synthesis. Modern pharmaceutical companies prioritize eco-friendly processes, and this compound's efficient preparation with minimal waste aligns with global Environmental, Social, and Governance (ESG) standards. Its applications extend to catalysis and ligand design, where it serves as a precursor for transition metal complexes.

Analytical characterization of CAS No. 719999-55-0 involves advanced techniques such as nuclear magnetic resonance (NMR), high-performance liquid chromatography (HPLC), and mass spectrometry (MS). These methods ensure purity and confirm the stereochemical integrity of the (2S)-pyrrolidin-2-yl configuration, which is crucial for its biological activity. The compound's stability under various pH conditions also makes it suitable for formulation studies in drug delivery systems.

Emerging trends in computational chemistry have further amplified interest in tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate. Molecular docking simulations and quantum mechanical calculations predict its interactions with proteins, aiding in rational drug design. Such in silico approaches reduce experimental costs and accelerate the discovery of novel therapeutics, particularly for neurodegenerative diseases and G-protein-coupled receptors (GPCRs).

In summary, tert-butyl N-{2-[(2S)-pyrrolidin-2-yl]ethyl}carbamate (CAS No. 719999-55-0) represents a pivotal compound in modern organic and medicinal chemistry. Its structural features, synthetic utility, and alignment with sustainable practices underscore its relevance in both academic and industrial settings. As research continues to explore its potential, this molecule remains a key player in the advancement of precision medicine and targeted therapies.

• 143444-83-1(CARBAMIC ACID, N-[(1S)-1-(3R)-3-PYRROLIDINYLETHYL]-, 1,1-DIMETHYLETHYL ESTER)
• 403479-18-5(tert-Butyl 8-azabicyclo[3.2.1]octan-3-ylcarbamate hydrochloride)
• 132234-68-5(tert-butyl N-[exo-8-azabicyclo[3.2.1]octan-3-yl]carbamate)
• 1268520-51-9(tert-butyl N-[(1S,3R)-3-(butylamino)cyclohexyl]carbamate)
• 351369-04-5(Carbamic acid, [1-(4-methyl-3-pyrrolidinyl)ethyl]-, 1,1-dimethylethylester)
• 454451-28-6(tert-butyl N-(azepan-4-yl)carbamate)
• 132234-69-6(tert-butyl N-[endo-8-azabicyclo[3.2.1]octan-3-yl]carbamate)
• 287114-25-4(tert-butyl N-(8-azabicyclo[3.2.1]octan-3-yl)carbamate)
• 1263378-93-3(tert-Butyl 2-(Pyrrolidin-2-Yl)ethylcarbamate)
• 720000-05-5(tert-butyl N-{2-[(2R)-pyrrolidin-2-yl]ethyl}carbamate)